The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers
Zhiyuan Hu(Fujian Medical University), Ahmed Ahmed(University of Oxford), Abdulkhaliq Alsaadi(University of Oxford), Laura Santana González(University of Oxford), Oloruntoba I. Osagie(University of Oxford), Stephen Damato(Oxford University Hospitals NHS Trust), Zhe Zhong(Central South University), Joanna Hester(University of Oxford), Haonan Lu(Ovarian Cancer Action), Nina Wietek(Churchill Hospital), Ashwag Albukhari(King Abdulaziz University), Sarah P. Blagden(Churchill Hospital), Mara Artibani(University of Oxford), Paula Cunnea(Imperial College London), Katherine Nixon(Imperial College London), Christopher Yau(University of Leeds), Eric O. Aboagye(Imperial College London), Sunanda Dhar(Oxford University Hospitals NHS Trust), Christina Fotopoulou(Ovarian Cancer Action), Leticia Campo(University of Oxford), Jennifer Ploski(Imperial College London)
Cited by 23
Related Papers
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2013|1.1k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926